Use of roughness maps in visualisation of surfaces
Research output: Contribution to journal › Journal article › peer-review
Standard
Use of roughness maps in visualisation of surfaces. / Seitavuopio, Paulus; Rantanen, Jukka; Yliruusi, Jouko.
In: European Journal of Pharmaceutics and Biopharmaceutics, Vol. 59, No. 2, 02.2005, p. 351-8.Research output: Contribution to journal › Journal article › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Use of roughness maps in visualisation of surfaces
AU - Seitavuopio, Paulus
AU - Rantanen, Jukka
AU - Yliruusi, Jouko
PY - 2005/2
Y1 - 2005/2
N2 - In this study we will present a new method to describe surface roughness. This method builds a roughness map of the studied area. The roughness map can give information of localised roughness. The test surfaces used in the evaluation of the method were tablets, which were made of lactose monohydrate, theophylline anhydrate, sodium chloride and potassium chloride. The roughness determinations were made by a laser profilometer. The new matrix method gives detailed roughness maps, which are able to show local variations in surface roughness values and provide an illustrative picture of the heterogeneity of surface roughness of various materials.
AB - In this study we will present a new method to describe surface roughness. This method builds a roughness map of the studied area. The roughness map can give information of localised roughness. The test surfaces used in the evaluation of the method were tablets, which were made of lactose monohydrate, theophylline anhydrate, sodium chloride and potassium chloride. The roughness determinations were made by a laser profilometer. The new matrix method gives detailed roughness maps, which are able to show local variations in surface roughness values and provide an illustrative picture of the heterogeneity of surface roughness of various materials.
KW - Imaging, Three-Dimensional
KW - Lasers
KW - Microscopy, Electron, Scanning
KW - Surface Properties
KW - Tablets
U2 - 10.1016/j.ejpb.2004.08.009
DO - 10.1016/j.ejpb.2004.08.009
M3 - Journal article
C2 - 15661508
VL - 59
SP - 351
EP - 358
JO - European Journal of Pharmaceutics and Biopharmaceutics
JF - European Journal of Pharmaceutics and Biopharmaceutics
SN - 0939-6411
IS - 2
ER -
ID: 140621905